Latest filing published 29 Feb 2024 for Lexicon Pharmaceuticals, INC..
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +16.4%Entry US$1.40 · Close at T+365 US$1.63
- -23.9%Entry US$2.30 · Close at T+365 US$1.75
- -16.6%Entry US$10.16 · Close at T+365 US$8.47
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jeffrey L. Wade: trading record in brief
This profile gathers the share dealings of Jeffrey L. Wade in Lexicon Pharmaceuticals, Inc., where the filings describe the role as chief executive. In total, 69 filings cover trades dated from 12 February 2009 to 28 February 2024.
Every open-market trade on record is a purchase: 4 purchases worth €55k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 21 share grants and 44 option exercises.
In size, the median ticket on the buying side is €15k. Clusters matter here: 3 out of 4 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Ninety days after publication, 4 purchases show a median change of -27.8%, with the price up in 0% of them. These figures describe past trades and do not predict future prices.
The newest entry dates from 29 February 2024: an option exercise, in Lexicon Pharmaceuticals, Inc. The last purchase on record was published on 14 September 2023, which is 1,152 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jeffrey L. Wade
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 37,274 sharesCommon StockSEC:0001127602-24-007628:1
- 49,113 sharesCommon StockSEC:0001127602-24-007628:2
- 37,691 shares@ US$2.6212.9% of flowCommon StockSEC:0001127602-24-007628:3
- 11,177 sharesCommon StockSEC:0001127602-24-007628:0
- 10,000 shares@ US$1.3837.8% of flowCommon StockSEC:0001127602-23-024201:0Canonical exit: 13 Dec 2023 (T+90)
- 2,000 shares@ US$2.330.6% of flowCommon StockSEC:0001127602-23-018978:1Canonical exit: 18 Sept 2023 (T+90)
- 10,000 shares@ US$2.33562.2% of flowCommon StockSEC:0001127602-23-018978:0Canonical exit: 18 Sept 2023 (T+90)
- 30,255 shares@ US$2.178.8% of flowCommon StockSEC:0001127602-23-007917:3
- 11,176 sharesCommon StockSEC:0001127602-23-007917:1
- 37,273 sharesCommon StockSEC:0001127602-23-007917:2
- 30,467 sharesCommon StockSEC:0001127602-23-007917:0
- 25,773 shares@ US$2.859.3% of flowCommon StockSEC:0001127602-22-007168:3
- 30,466 sharesCommon StockSEC:0001127602-22-007168:1
- 11,177 sharesCommon StockSEC:0001127602-22-007168:2
- 25,290 sharesCommon StockSEC:0001127602-22-007168:0
- 26,584 shares@ US$7.1932.6% of flowCommon StockSEC:0001127602-21-008779:4
- 2,797 sharesCommon StockSEC:0001127602-21-008779:0
- 9,555 sharesCommon StockSEC:0001127602-21-008779:1
- 25,290 sharesCommon StockSEC:0001127602-21-008779:2
- 30,467 sharesCommon StockSEC:0001127602-21-008779:3
- 9,651 shares@ US$1.9619.0% of flowCommon StockSEC:0001127602-20-014495:1
- 26,525 shares0Common StockSEC:0001127602-20-014495:0
- 16,025 shares@ US$2.7743.8% of flowCommon StockSEC:0001127602-20-008971:4
- 4,495 sharesCommon StockSEC:0001127602-20-008971:0
- 2,798 sharesCommon StockSEC:0001127602-20-008971:1
25 of 67 declarations